Inventor
BECK ELIZABETH MARY
GB26 patents
⚠️ This page may combine multiple inventors who share the name “BECK ELIZABETH MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
20 patentsUS9428523B2Aug 30, 2016
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER12 citations92
US9315520B2Apr 19, 2016
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER15 citations92
US9198917B2Dec 1, 2015
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER14 citations92
US9045499B2Jun 2, 2015
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER17 citations92
US9045498B2Jun 2, 2015
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER18 citations92
US8865706B2Oct 21, 2014
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER19 citations92
US8822456B2Sep 2, 2014
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER19 citations92
US9260455B2Feb 16, 2016
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER7 citations84
US9233981B1Jan 12, 2016
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER12 citations84
US9192612B2Nov 24, 2015
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER13 citations84
US8962616B2Feb 24, 2015
Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
PFIZER18 citations84
US9845301B2Dec 19, 2017
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER8 citations83
US9605007B2Mar 28, 2017
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER8 citations83
US10604519B2Mar 31, 2020
5,7-dihydro-pyrrolo-pyridine derivatives
PFIZER3 citations72
US10428034B2Oct 1, 2019
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER3 citations72
US10028962B2Jul 24, 2018
2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER3 citations72
US9744173B2Aug 29, 2017
2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
PFIZER2 citations72
US11905284B2Feb 20, 2024
5,7-dihydro-pyrrolo-pyridine derivatives
PFIZER0 citations62
US10723711B2Jul 28, 2020
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
PFIZER0 citations51
US11198692B2Dec 14, 2021
Dihydro-pyrrolo-pyridine derivatives
PFIZER0 citations49
VERTEX PHARMA
6 patentsUS12247021B2Mar 11, 2025
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA1 citations72
US11834441B2Dec 5, 2023
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA4 citations72
US11919887B2Mar 5, 2024
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA2 citations71
US11827627B2Nov 28, 2023
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA3 citations71
US12258333B2Mar 25, 2025
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA0 citations60
US12503439B2Dec 23, 2025
Heteroaryl compounds for the treatment of pain
VERTEX PHARMA0 citations44